ARCHIVES

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987

Summit Conference Reviews Leads In Leukemia, Lymphoma

January 8, 1982

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

October 22, 2010

DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”

June 18, 1982

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011

DCE Board Approves Recompetition Of Two Major Contracts

October 30, 1987